X-Therma logo

Preserving Life by Emulating Nature

A robust preservation platform for cells, tissues, organs, and regenerative medicines.

We advance regenerative medicine and organ transplantation with a ground-breaking biopreservation platform. We enable safe and reliable organs, engineered tissues, and cell therapies to patients in need and break down the barriers of time and distance. 

You have Time.

Organ Transplant

Not Enough Time

Do you know 80% of transplantable organs end up NOT being transplanted today, especially for hearts and lungs?

90%

UNMET NEED

1/hour

Die on waitlist

80%

transplantable organs wasted

Just hours

to keep organs alive

In organ transplantation, we are racing against TIME on Ice every day, battling an extremely slim window where every minute matters. We currently perfuse and store an organ in preservation solution that is kept between 2-8°C in an igloo cooler on wet-ice. This only allows organ survival for less than a day. For the heart, that is an ephemeral 4 hrs. This extremely tight race severely hinders organ accessibility, breeds extreme risk, creates a logistics nightmare for the transplant team and significantly impacts patient survival. 

To win such a race, we MUST remove TIME from the equation. 

cGMP CELL & GENE THERAPY

DMSO and Serum No Longer Meet Integrated Demands

  • Poor post-thaw cell survival as low as 15-20%
  • Cell functionality impaired
  • Profound in vivo toxicity
  • Severe injection site pain/neurotoxicity
  • Adverse Genotoxicity

Nature, Scientific Reports volume 9, Article number: 4641 (2019)

  • Processing nightmare
  • Limited scale-up production
  • Batch variation

Biopreservation is the key for commercial cell manufacturing & processing, which happens 3-5 times throughout the process. However, preservation has seen little improvement. Existing standards use 5-10% dimethyl sulfoxide (DMSO) with serum. A new solution is needed to enable “off-the-shelf” living medicines.

In Vitro Fertilization

Can we say “No” to toxins for healthy babies?

DMSO

Adverse Toxicity & Genotoxicity

Poor Functional Recovery <10% (human eggs)

In Vitro Fertilization uses a high concentration of toxic vitrification media to freeze eggs or embryos that can kill a cat just in one teaspoon taken orally. This causes severe cell shrinkage and damage to the cell membrane, ultimately leading to a negative impact on the viability of the eggs, giving less than 10% with functional recovery.

The extreme changes in microRNAs and alterations in the epigenetic landscape indicate that DMSO is not inert. Its use should be reconsidered, especially for preservation of embryos and oocytes, since it may impact embryonic development.

Nature, Scientific Reports volume 9, Article number: 4641 (2019)

Organ Transplant

Not Enough Time

Do you know 80% of transplantable organs end up NOT being transplanted today, especially for hearts and lungs?

90%

UNMET NEED

1/hour

Die on waitlist

80%

transplantable organs wasted

Just hours

to keep organs alive

In organ transplantation, we are racing against TIME on Ice every day, battling an extremely slim window where every minute matters. We currently perfuse and store an organ in preservation solution that is kept between 2-8°C in an igloo cooler on wet-ice. This only allows organ survival for less than a day. For the heart, that is an ephemeral 4 hrs. This extremely tight race severely hinders organ accessibility, breeds extreme risk, creates a logistics nightmare for the transplant team and significantly impacts patient survival. 

To win such a race, we MUST remove TIME from the equation. 

cGMP CELL & GENE THERAPY

DMSO and Serum No Longer Meet Integrated Demands

  • Poor post-thaw cell survival as low as 15-20%
  • Cell functionality impaired
  • Profound in vivo toxicity
  • Severe injection site pain/neurotoxicity
  • Adverse Genotoxicity

Nature, Scientific Reports volume 9, Article number: 4641 (2019)

  • Processing nightmare
  • Limited scale-up production
  • Batch variation

Biopreservation is the key for commercial cell manufacturing & processing, which happens 3-5 times throughout the process. However, preservation has seen little improvement. Existing standards use 5-10% dimethyl sulfoxide (DMSO) with serum. A new solution is needed to enable “off-the-shelf” living medicines.

In Vitro Fertilization

Can we say “No” to toxins for healthy babies?

DMSO

Adverse Toxicity & Genotoxicity

Poor Functional Recovery <10% (human eggs)

In Vitro Fertilization uses a high concentration of toxic vitrification media to freeze eggs or embryos that can kill a cat just in one teaspoon taken orally. This causes severe cell shrinkage and damage to the cell membrane, ultimately leading to a negative impact on the viability of the eggs, giving less than 10% with functional recovery.

The extreme changes in microRNAs and alterations in the epigenetic landscape indicate that DMSO is not inert. Its use should be reconsidered, especially for preservation of embryos and oocytes, since it may impact embryonic development.

Nature, Scientific Reports volume 9, Article number: 4641 (2019)

"Look deep into nature, and then you will understand everything better. "

-Albert Einstein

Arctic fish thrive in sub-zero environments because of Antifreeze Proteins (AFPs) that reduce the freezing point of water and bind nucleated ice to control the growth of lethal ice crystals. Inspired by AFPs, we developed a chemically defined antifreeze molecule that is hyper effective, non-toxic, biocompatible, and scalable.

XT-Thrive®

Chemically Defined Safe & Effective Cryopreservation

XT-Thrive® is a DMSO-free, serum-free, protein-free, and chemically defined cryopreservation media for the preservation of mammalian cells at ultra-low temperatures (-70° C to -196° C). It is a non-toxic & hyper-effective alternative to DMSO and serum products. It is plug and play for cell & tissue manufacturing processes.

XT-ViVo®

Organ and Tissue Preservation Solution

XT-ViVo® is a novel subzero preservation solution that will enable safe long-term ice-free storage and transport for tissues and organs. XT-ViVo® has been designated as a Breakthrough Device by the FDA.

TimeSeal®

Organ and tissue transport device

TimeSeal® is a passively cooled device for subzero organ and tissue transport. TimeSeal® does not alter the current organ procurement process or the peri-transplant workflow. Its ease of use is a significant advantage for use in the operating room as an unparalleled solution that can extend organ life.
NORTH AMERICA

2600 Hilltop Drive
Suite B220
Richmond, CA 94806
USA

EUROPE

Kaiserjägerstraße 30
6020 Innsbruck
Austria